openPR Logo
Press release

mAb Biosimilars Market Thrives as Cost-effective Alternatives Fuel Adoption | Samsung Bioepis | Amgen | Biocon

05-12-2025 06:17 PM CET | Health & Medicine

Press release from: Coherent Market Insights

mAb Biosimilars Market

mAb Biosimilars Market

mAb Biosimilars Market Overview

mAb Biosimilars Market is estimated to grow from USD 9.4 billion in 2025 to USD 22.7 billion by 2032, at a CAGR of 13.3%.

Coherent Market Insights is pleased to release its latest mAb Biosimilars Market research report, offering an in-depth analysis of the U.S. mAb Biosimilars Market Landscape from 2025 to 2032. This report delivers reliable projections across national and regional levels, encompassing supply chain shifts, payer-provider dynamics, and competitive intelligence. The U.S. Healthcare Industry continues to advance rapidly, fueled by the rising burden of chronic conditions, growing healthcare expenditure, and innovations in biotechnology and digital health. Our report presents a comprehensive assessment of market forces-from value-based care and patient-centric models to policy and regulatory transformations shaping the future of healthcare delivery.

💡Request Your Sample Copy of the US Tariff Impact Analysis Now: - https://www.coherentmarketresearch.com/samplepages/90517

Driving Strategic and Clinical Excellence

This healthcare-focused report serves stakeholders across the care continuum-including providers, payers, investors, and executives-with actionable market intelligence on the evolving U.S. Health Ecosystem. It provides segmentation by therapeutic specialties, care delivery models, and payer categories. Insights are validated by clinical experts and policy analysts. Methodology includes clinical trial reviews, reimbursement trends, and patient outcome benchmarking-supported with data visualizations, dashboards, and region-specific analysis.

Key therapeutic areas covered include oncology, cardiovascular disease, and rare disorders, along with rising trends such as AI-enabled diagnostics, telehealth adoption, and personalized medicine. This report enables informed decision-making aligned with changing reimbursement models, regulatory standards, and patient expectations in the U.S. mAb Biosimilars Market.

📌 Key Healthcare Companies Profiled:

◘ Amgen
◘ Samsung Bioepis
◘ Biocon
◘ Pfizer
◘ Sandoz.

⏩ Market Segmentation:

Product Type: Monoclonal Antibodies, Insulin, Erythropoietin, Somatropin

Application: Oncology, Chronic and Autoimmune Disorders

Manufacturer: In-house, Contract Research and Manufacturing Services

📊 Report Scope

This report provides a dual focus on the U.S. and Global mAb Biosimilars Markets, analyzing federal and state policy developments, payer reforms, CMS programs, and FDA regulatory updates. It examines historical benchmarks and forecasts for revenue and patient volumes. Technologies reviewed include EHR systems, medical devices, precision therapeutics, and mobile health (mHealth) platforms.

The report also evaluates equity initiatives, provider shortages, and insurance coverage disparities, offering data-driven strategies for navigating risks and enabling growth across the U.S. healthcare economy.

📌 Research Methodology:

Our research combines primary interviews with healthcare providers, health system executives, and policymakers, with secondary data from CDC, CMS, FDA, and leading peer-reviewed journals. This ensures that the mAb Biosimilars Market analysis remains both clinically accurate and business-relevant.

🗺️ U.S. Regional Market Deep Dive:

Northeast: New York, Massachusetts, Pennsylvania
Midwest: Illinois, Ohio, Michigan
South: Texas, Florida, Georgia
West: California, Washington, Arizona

Each region includes evaluation of health system infrastructure, demographic needs, reimbursement trends, and digital innovation readiness.

✅Get Up to 70% Discount on the US Tariff Impact Analysis Report : https://www.coherentmarketinsights.com/promo/buynow/90517

Read More Trending Articles

Monoclonal Antibody Therapeutics Market - https://www.globenewswire.com/news-release/2023/04/12/2645360/0/en/Monoclonal-Antibody-Therapeutics-Market-to-Surpass-US-534-26-Billion-by-2030-Says-Coherent-Market-Insights-CMI.html#:~:text=Burlingame%2C%20April%2012%2C%202023%20(,period%20(2023%2D2030).

Neurofeedback Market - https://www.globenewswire.com/news-release/2023/04/13/2646204/0/en/Neurofeedback-Market-to-Surpass-US-2-056-9-Million-by-2030-Says-Coherent-Market-Insights-CMI.html#:~:text=Burlingame%2C%20April%2013%2C%202023%20(,period%20(2023%2D2030).

Surgical Drills Market - https://www.globenewswire.com/news-release/2023/04/14/2647040/0/en/Surgical-Drills-Market-to-Surpass-US-1-030-1-Million-by-2030-Says-Coherent-Market-Insights-CMI.html#:~:text=Burlingame%2C%20April%2014%2C%202023%20(,period%20(2023%2D2030).

Over the Counter (OTC) Analgesics Market - https://www.globenewswire.com/news-release/2023/06/23/2693711/0/en/Over-the-Counter-OTC-Analgesics-Market-to-Reach-US-39-74-Billion-by-2030-Says-Coherent-Market-Insights.html

Pigmentation Disorders Treatment Market - https://www.globenewswire.com/en/news-release/2023/06/26/2694516/0/en/Pigmentation-Disorders-Treatment-Market-to-Reach-US-9-68-Billion-by-2028-Coherent-Market-Insights.html

💬 Key Questions Addressed in This Healthcare Report:

(1) Who are the leading healthcare companies in the U.S. market?
(2) What technological and clinical trends will shape healthcare delivery by 2032?
(3) How are providers responding to regulatory shifts from CMS and FDA?
(4) What payer strategies are optimizing outcomes and lowering costs?
(5) Which segments are most influenced by precision medicine and remote monitoring?
(6) How will healthcare policy reforms impact the U.S. economy?
(7) What is the projected growth trajectory for the U.S. healthcare sector?

✍️ Report Author:
Vaagisha is a seasoned healthcare content editor with over three years of experience in medical market analysis. With a life sciences background and a sharp editorial lens, she ensures every report is clinically precise, regulatory-compliant, and strategically aligned for healthcare stakeholders.

About Coherent Market Insights

Coherent Market Insights is a globally trusted mAb Biosimilars Market intelligence and consulting firm offering evidence-based research reports and strategic advisory services. Specializing in pharmaceuticals, medical devices, digital health, and hospital systems, we support health systems, biopharma leaders, policymakers, and medtech innovators with insights tailored for a post-pandemic landscape.

☎️ Contact Us:
Mr. Shah
Senior Client Partner - Business Development
Coherent Market Insights
📞 US: +1-206-701-6702
📞 UK: +44-020-8133-4027
📞 AUS: +61-2-4786-0457
📞 India: +91-848-285-0837
✉ Email: sales@coherentmarketinsights.com

🌐 Website: www.coherentmarketinsights.com
Follow us: LinkedIn | Twitter

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release mAb Biosimilars Market Thrives as Cost-effective Alternatives Fuel Adoption | Samsung Bioepis | Amgen | Biocon here

News-ID: 4011491 • Views:

More Releases from Coherent Market Insights

Thin Film Solar Cell Market to Get an Explosive Growth 2025 | Ascent Solar Technologies, Inc., FIRST SOLAR, Kaneka Corporation
Thin Film Solar Cell Market to Get an Explosive Growth 2025 | Ascent Solar Techn …
The latest report from Coherent Market Insights examines the growth prospects of the Thin Film Solar Cell Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth factors, and regional forecasts. The report provides a comprehensive overview by integrating research findings, market assessments, and data from various sources. It explores crucial market dynamics, including drivers, restraints, challenges, and potential risks, while also identifying
Rising Trends of Ultra-Thin Glass Market Outlook 2025-2032: Growth Drivers, Share, And Trends As Revealed In New Report | Corning Inc. , AGC Inc., , Schott AG
Rising Trends of Ultra-Thin Glass Market Outlook 2025-2032: Growth Drivers, Shar …
The latest report from Coherent Market Insights examines the growth prospects of the Ultra-Thin Glass Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth factors, and regional forecasts. The report provides a comprehensive overview by integrating research findings, market assessments, and data from various sources. It explores crucial market dynamics, including drivers, restraints, challenges, and potential risks, while also identifying growth opportunities,
Rapid Diagnostics Market Set to Witness Massive Growth by 2032 | Abbott, Danaher, Quidel, BD
Rapid Diagnostics Market Set to Witness Massive Growth by 2032 | Abbott, Danaher …
The latest report from Coherent Market Insights examines the growth prospects of the Rapid Diagnostics Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth factors, and regional forecasts. The report provides a comprehensive overview by integrating research findings, market assessments, and data from various sources. It explores crucial market dynamics, including drivers, restraints, challenges, and potential risks, while also identifying growth opportunities,
U.S. Digital Therapeutics Market Set to Witness Significant Growth by 2025-2032 | 2Morrow Inc., ResMed, Pear Therapeutics, Omada Health Inc.
U.S. Digital Therapeutics Market Set to Witness Significant Growth by 2025-2032 …
The latest report from Coherent Market Insights examines the growth prospects of the U.S. Digital Therapeutics Market from 2025 to 2032. This in-depth analysis covers industry size, market share, business trends, key growth factors, and regional forecasts. The report provides a comprehensive overview by integrating research findings, market assessments, and data from various sources. It explores crucial market dynamics, including drivers, restraints, challenges, and potential risks, while also identifying growth

All 5 Releases


More Releases for Biosimilars

Transformative Trends Impacting the Biosimilars Market Landscape: Innovative Pro …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Biosimilars Market Size Valuation Forecast: What Will the Market Be Worth by 2025? The dimensions of the biosimilars market have been rapidly expanding over the last couple of years. The escalation, from a worth of $18.65 billion in 2024 to an estimated value of $21.95 billion in 2025, denotes
Evolving Market Trends In The Biosimilars Industry: Innovative Product Launched …
The Biosimilars Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories]. What Is the Expected Biosimilars Market Size During the Forecast Period? The dimension of the biosimilars market has experienced substantial expansion in the last few years. The market value, which was at $18.65 billion in 2024,
Prominent Rituximab Biosimilars Market Trend for 2025: Collaborative Innovations …
Which drivers are expected to have the greatest impact on the over the rituximab biosimilars market's growth? The rituximab biosimilars market is anticipated to grow due to the projected increase in non-Hodgkin's lymphoma (NHL) cases. NHL is a cancer that originates in the white blood cells and lymphocytes, which are integral parts of the body's immune system. For example, the American Cancer Society, a cancer advocacy group based in the US,
Global Oncology Biosimilars Market | Global Oncology Biosimilars Industry | Onco …
The oncology biosimilars market involves of sales of medicine and drug interrelated products for cancer treatment. Biosimilars are pharmaceuticals which are produced using cell lines and are fashionable to the manufacturer. The manufacturing of such cell line processes is a multipart and time-consuming procedure. According to the report analysis, ‘Oncology Biosimilars Market Global Report 2020-30’ states that the worldwide oncology biosimilars market was worth USD 2990.34 million in 2019. It is
Global Biosimilars Market | Global Biosimilars Industry | Global Biosimilars Mar …
The biosimilars market involves of sales of biosimilars and associated services that are cast-off to treat chronic sicknesses such as diabetes, arthritis, and cancer. The Biosimilars are pharmaceuticals that are produced using cell lines and offers no clinical difference as linked to biologics. The Biosimilars are made once the patent of biologics is deceased. According to the report analysis, ‘Biosimilars Market Global Report 2020-30’ states that the worldwide biosimilars market was
Insulin Biosimilars Market, by Biosimilar Type Rapid-acting Biosimilars, Long-ac …
Diabetes is a group of metabolic disease characterized by high blood sugar level due to inadequate secretion of insulin. Common symptoms of diabetes include increased hunger, tiredness, weight loss, and excessive thirst and urination. The prevalence of diabetes is increasing, in turn, boosting demand for insulin biosimilar. For instance, according the World Health Organization (WHO) report in 2014, globally around 422 million adults were living with diabetes and 1.5 million